Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Dibenzyl Trisulphide as a Chemotherapeutic Agent in Stage Four Cancer of the Breast, Prostate, Cervix and Colon

NCT04113096 is registered in ClinicalTrials.gov with The University of The West Indies as lead sponsor.

NCT NCT04113096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04113096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Dibenzyl Trisulphide as a Chemotherapeutic Agent in Stage Four Cancer of the Breast, Prostate, Cervix and Colon
Lead sponsor
The University of The West Indies
Phase
Phase 1
Overall status
Unknown status
Start date
October 1, 2018
Completion date
September 30, 2020
Enrollment
104 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iv breast cancer, stage iv cancer of the cervix, stage iv colon cancer, stage iv prostate cancer